Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate)

Journal of Drug Targeting

Volumn 8, Issue 3, 2000, Pages 165-172

  Jaulin, N ^b   Appel, M ^b   Passirani, C ^b   Barratt, G ^b   Labarre, D ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b Univ Paris 11 ^*

Author keywords

Core shell nanoparticles; Dextran; Heparin; J774A1 Macrophagic cell line; Phagocytosis; Poly(methyl methacrylate)

Indexed keywords

CARBAZOLE DERIVATIVE; COPOLYMER; DEXTRAN; HEPARIN; NANODEX; NANOHEP; NANOPARTICLE; POLY(METHYL METHACRYLATE); POLYSACCHARIDE; RADICAL; UNCLASSIFIED DRUG; VINYL DERIVATIVE;

ADSORPTION; ANIMAL CELL; ARTICLE; BIODEGRADATION; CELL LINE; CONTROLLED STUDY; COVALENT BOND; DRUG UPTAKE; FLUORESCENCE; IMAGING; IN VITRO STUDY; INTERNALIZATION; LOW TEMPERATURE; MACROPHAGE; MEASUREMENT; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PHAGOCYTOSIS; POLYMERIZATION; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 0033861347     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611860008996862     Document Type: Article

References (24)

1. Large unilamellar liposomes with low uptake into the reticuloendothelial system
2. Stealth Me.PEGPLA nanoparticles avoid uptake by the mononuclear phagocytes system
3. The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives
4. Anti-inflammatory effects of heparin and its derivatives. Inhibition of complement and of lymphocyte migration
5. The role of complement in inflammation and phagocytosis
6. Biodegradable long-circulating polymeric nanospheres
7. Protein-surface interactions in the presence of polyethylene oxide I. Simplified theory
8. Protein-surface interactions in the presence of polyethylene oxide II. Effect of protein size
9. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b
10. Heparin-like polymer surfaces: Control of coagulation and complement activation by insoluble functionalized polymers Inter
11. Heparin prevents formation of the human C3 amplification convertase by inhibiting the binding site for B on C3b
12. Covalent binding of heparin to a vinyl copolymer for biomedical applications
13. A new model for evaluation of biocompatibility: Combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin
14. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
15. Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: Comparison to PEG
16. Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system
17. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate)
18. Preparation and characterization of nanoparticles bearing heparin or dextran covalently-linked to poly(methyl methacrylate)
19. Complement activation by polymethyl methacrylate minimized by end-point heparin attachment
20. Polymeric micro- and nanoparticles as drug carriers
21. Interactions of poly(lactic acid) and poly(lactic acid-coethylene oxide) nanoparticles with the plasma factors of the coagulation system
22. Morphological, cytochemical, functional and proliferative characteristics of four macrophage-like cell lines
23. Effect of PEO surface density on long-Circulating nanoparticles which are low complement activators
24. Modulation of the formation of the amplification convertase of complement C3bBb, by native and commercial heparin